| Primary |
| Drug Use For Unknown Indication |
15.8% |
| Staphylococcal Infection |
15.8% |
| Systemic Lupus Erythematosus |
13.2% |
| Abdominal Wall Cyst |
5.3% |
| Infection Mrsa |
5.3% |
| Nasal Discomfort |
5.3% |
| Skin Lesion |
5.3% |
| Anal Abscess |
2.6% |
| Bacterial Rhinitis |
2.6% |
| Cellulitis |
2.6% |
| Impetigo |
2.6% |
| Infected Bites |
2.6% |
| Infection Prophylaxis |
2.6% |
| Laceration |
2.6% |
| Lip Injury |
2.6% |
| Nasal Irrigation |
2.6% |
| Preoperative Care |
2.6% |
| Rhinalgia |
2.6% |
| Skin Cancer |
2.6% |
| Skin Disorder |
2.6% |
|
| Rash |
13.8% |
| Teratogenicity |
10.3% |
| Vomiting |
10.3% |
| Application Site Pruritus |
6.9% |
| Skin Inflammation |
6.9% |
| Anal Pruritus |
3.4% |
| Application Site Pain |
3.4% |
| Dermatitis Contact |
3.4% |
| Drug Administration Error |
3.4% |
| Drug Resistance |
3.4% |
| Fungal Infection |
3.4% |
| Infection |
3.4% |
| Maternal Drugs Affecting Foetus |
3.4% |
| Nasal Discomfort |
3.4% |
| Nausea |
3.4% |
| Ocular Hyperaemia |
3.4% |
| Oropharyngeal Pain |
3.4% |
| Palpitations |
3.4% |
| Pancreatitis |
3.4% |
| Product Contamination Microbial |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
48.9% |
| Drug Use For Unknown Indication |
12.9% |
| Systemic Lupus Erythematosus |
12.9% |
| Hypertension |
6.4% |
| Antifungal Prophylaxis |
3.9% |
| Acne |
2.4% |
| Drug Exposure During Pregnancy |
2.1% |
| Muscle Spasms |
2.1% |
| Prophylaxis |
2.1% |
| Pain |
1.1% |
| Inflammatory Bowel Disease |
0.9% |
| Muscle Spasticity |
0.9% |
| Hypersensitivity |
0.8% |
| Stevens-johnson Syndrome |
0.6% |
| Multiple Allergies |
0.5% |
| Sleep Disorder |
0.5% |
| Glaucoma |
0.3% |
| Impetigo |
0.3% |
| Open Wound |
0.3% |
| Stress |
0.3% |
|
| Teratogenicity |
20.9% |
| Vestibular Disorder |
11.6% |
| Cheilitis |
10.5% |
| Cytomegalovirus Infection |
8.1% |
| Maternal Drugs Affecting Foetus |
8.1% |
| Aspergillosis |
7.0% |
| Drug Exposure During Pregnancy |
4.7% |
| Pain |
4.7% |
| Staphylococcal Infection |
4.7% |
| Urinary Tract Infection |
4.7% |
| Nasal Vestibulitis |
3.5% |
| Impetigo |
2.3% |
| Application Site Irritation |
1.2% |
| Dermatitis |
1.2% |
| Epistaxis |
1.2% |
| Gastrointestinal Haemorrhage |
1.2% |
| Hepatic Steatosis |
1.2% |
| Mouth Haemorrhage |
1.2% |
| Oropharyngeal Pain |
1.2% |
| Pregnancy |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
53.0% |
| Drug Use For Unknown Indication |
24.8% |
| Pain |
3.8% |
| Hypertension |
1.7% |
| Prophylaxis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Nausea |
1.4% |
| Depression |
1.3% |
| Breast Cancer |
1.3% |
| Constipation |
1.3% |
| Rheumatoid Arthritis |
1.0% |
| Anxiety |
1.0% |
| Crohn's Disease |
0.9% |
| Asthma |
0.9% |
| Peritoneal Dialysis |
0.9% |
| Diarrhoea |
0.8% |
| Contraception |
0.8% |
| Eczema |
0.7% |
| Inflammatory Bowel Disease |
0.7% |
| Osteoporosis |
0.7% |
|
| Vomiting |
20.9% |
| Weight Decreased |
7.2% |
| Wound Infection Staphylococcal |
7.2% |
| Thrombocytopenia |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Pulmonary Embolism |
4.7% |
| Skin Ulcer |
4.7% |
| Visual Impairment |
4.7% |
| Urinary Tract Infection |
4.3% |
| Transient Ischaemic Attack |
3.8% |
| Crohn's Disease |
3.4% |
| Death |
3.4% |
| Nausea |
3.4% |
| Pain |
3.4% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Peritonitis |
3.0% |
| Urosepsis |
3.0% |
| Depression |
2.6% |
|
